Erudio Healtherudio.com
Drug
Cabazitaxel trials: what clinicians said in public
No HCP commentary report on a trial studying cabazitaxel yet. Erudio has found public clinician commentary on 9 clinical trials studying cabazitaxel, including C3NIRA, CheckMate 650, LuCAB and TheraP. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| CheckMate 650 NCT02985957 · Bristol-Myers Squibb DeepView → | metastatic castration-resistant prostate cancer | Phase 2 | Deep | View | |||
| LuCAB NCT05340374 · Peter MacCallum Cancer Centre, Australia DeepView → | metastatic castration-resistant prostate cancer | Phase 1/Phase 2 | Deep | View | |||
| C3NIRA NCT04592237 · M.D. Anderson Cancer Center FocusedView → | aggressive variant metastatic prostate cancer | Phase 2 | Focused | View | |||
| TheraP NCT03392428 · Australian and New Zealand Urogenital and Prostate Cancer Trials Group FocusedView → | metastatic castration-resistant prostate cancer | Phase 2 | Focused | View | |||
| CABASTY NCT02961257 · Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie FocusedView → | docetaxel-treated metastatic castration-resistant prostate cancer in older men | Phase 3 | Focused | View | |||
| XALience NCT07213674 · Amgen FocusedView → | chemotherapy-naïve metastatic castration-resistant prostate cancer | Phase 3 | Focused | View | |||
| NCT02254785 NCT02254785 · British Columbia Cancer Agency FocusedView → | Not given | Phase 2 | Focused | View | |||
| NCT02703623 NCT02703623 · M.D. Anderson Cancer Center FocusedView → | metastatic castration-resistant prostate cancer | Phase 2 | Focused | View | |||
| XALute NCT06691984 · Amgen FocusedView → | metastatic castration-resistant prostate cancer previously treated with chemotherapy | Phase 3 | Focused | View | |||